A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Butobarbital
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Umeclidinium.
Butobarbital
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Umeclidinium.
Butobarbital
Lofentanil
The risk or severity of adverse effects can be increased when Lofentanil is combined with Umeclidinium.
Butobarbital
Ketobemidone
The risk or severity of adverse effects can be increased when Ketobemidone is combined with Umeclidinium.
Butobarbital
Dihydromorphine
The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Umeclidinium.
Butobarbital
Alphacetylmethadol
The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Umeclidinium.
Butobarbital
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Umeclidinium.
Butobarbital
Carfentanil
The risk or severity of adverse effects can be increased when Carfentanil is combined with Umeclidinium.
Butobarbital
Desomorphine
The risk or severity of adverse effects can be increased when Desomorphine is combined with Umeclidinium.
Butobarbital
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Umeclidinium.
Butobarbital
Etorphine
The risk or severity of adverse effects can be increased when Etorphine is combined with Umeclidinium.
Butobarbital
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Umeclidinium.
Butobarbital
Diamorphine
The risk or severity of adverse effects can be increased when Diamorphine is combined with Umeclidinium.
Butobarbital
Dihydroetorphine
The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Umeclidinium.
Butobarbital
Methadyl acetate
The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Umeclidinium.
Butobarbital
Bezitramide
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Bezitramide.
Butobarbital
Ramosetron
The risk or severity of constipation can be increased when Umeclidinium is combined with Ramosetron.
Butobarbital
Eluxadoline
The risk or severity of constipation can be increased when Umeclidinium is combined with Eluxadoline.
Butobarbital
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Umeclidinium.
Butobarbital
Timepidium
The risk or severity of adverse effects can be increased when Timepidium is combined with Umeclidinium.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3